A Study Evaluating the Efficacy and Safety on Moderate to Severe Dry Eye

NCT04092907 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye

Interventions

DRUG: HBM9036 0.25% Ophthalmic Solution
DRUG: placebo

Sponsor

Harbour BioMed (Guangzhou) Co. Ltd.